Description

2-[7-(1,3-Dimethylpyrazol-4-Yl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl]Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. It is essential for research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, especially within oncology and anti-inflammatory research pipelines.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates targeting specific biological pathways.
• Oncology Research: Used in the development of potential kinase inhibitors and other targeted cancer therapies due to its triazolopyrimidine core.
• Anti-inflammatory Drug Development: Serves as a building block for compounds being investigated for inflammatory and autoimmune disorders.
• Agrochemical Research: Potential intermediate in the discovery of new herbicides or fungicides, leveraging its heterocyclic bioactivity.
• Chemical Biology & Proteomics: Utilized as a molecular scaffold or tagging agent in probe development for studying enzyme function.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	2-[7-(1,3-Dimethylpyrazol-4-Yl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl]Acetic Acid
CAS No.	1174878-01-3
Molecular Formula	C₁₄H₁₃N₅O₂
Molecular Weight	283.29 g/mol
Synonyms	2-{7-[1,3-Dimethyl-1H-pyrazol-4-yl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl}acetic acid; [1,2,4]Triazolo[1,5-a]pyrimidine-2-acetic acid, 7-(1,3-dimethyl-1H-pyrazol-4-yl)-; 2-(7-(1,3-Dimethyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)acetic acid; 1174878-01-3; 2-[7-(1,3-Dimethyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]acetic acid
EINECS	Contact for details

Quality Control

Every batch of 2-[7-(1,3-Dimethylpyrazol-4-Yl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl]Acetic Acid is manufactured under strict quality management systems. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency meet the exacting standards required for pharmaceutical R&D and scale-up. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.